The first ‘Manipal cGMP Forum: National Conference on cGMP & Compliance’, will be a day dealing with the theme “cGMP for Sustainable Quality”, will take place on October 10, 2025 at the Dr TMA Pai Auditorium, MAHE, Manipal.
Novo Nordisk revealed the findings of the REACH real-world study, which showed that Ozempic (once-weekly injectable semaglutide) was linked to a 23% lower risk of major adverse cardiovascular events like a heart attack or stroke when compared to
.jpeg "Indegene and Datavant Enters Strategic Partnership")
Datavant, the healthcare data collaboration network, has declared its strategic collaboration with Indegene to improve the effectiveness of recruitment in complicated studies.
Piramal Pharma Solutions (PPS), a global leader in contract development and manufacturing (CDMO) and a division of Piramal Pharma Ltd., has announced the installation of a cutting-edge Korsch XM-12 bilayer tablet press at its Morpeth facility in the
The National Institutes of Health (NIH) launched an initiative to advance research on whole person health that aims to create the first integrated knowledge network of healthy physiological function. This initiative takes a health approach...
Eli Lilly and Company announced promising topline findings from its ACHIEVE-3 Phase 3 study, revealing that their investigational GLP-1 receptor agonist, orforglipron, which is administered orally once a day, was associated with better results...
.jpeg "Eli Lilly to Launch Weight-Loss Pill in India Soon")
Eli Lilly is preparing to introduce Orforglipron, its experimental oral weight-loss drug, in India, after the successful launch of its injectable therapy Mounjaro (tirzepatide) earlier this year. According to company executives
Metropolis Healthcare, a diagnostics company with its headquarters in Mumbai, stated on Thursday that it has paid Rs 17 crore to acquire Ambika Pathology Laboratory, located in Kolhapur.A deferred component of Rs 1.7 crore is included in the consider
Sai Life Sciences, a contract research, development, and manufacturing organization (CRDMO) focused on innovative medicines, announced Unit VI inauguration in Bidar, India, to manufacture veterinary active pharmaceutical...
Biocon Biologics Ltd, a fully integrated global biosimilars company and a unit of Biocon Ltd, has obtained the US Food and Drug Administration (FDA) approval for their denosumab biosimilars
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")